ID	Gene Name	Species	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DISEASE	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
ENSG00000253846	protocadherin gamma subfamily A, 10(PCDHGA10)	Homo sapiens	GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,	GO:0005886~plasma membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin-like_dom,IPR013164:Cadherin_N,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,IPR031904:Cadherin_CBD,IPR032455:Cadherin_C,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
ENSG00000108439	pyridoxamine 5'-phosphate oxidase(PNPO)	Homo sapiens	GO:0008615~pyridoxine biosynthetic process,GO:0042818~pyridoxamine metabolic process,GO:0042823~pyridoxal phosphate biosynthetic process,	GO:0005829~cytosol,	GO:0004733~pyridoxamine-phosphate oxidase activity,GO:0005515~protein binding,GO:0010181~FMN binding,GO:0030170~pyridoxal phosphate binding,GO:0042803~protein homodimerization activity,	IPR000659:Pyridox_Oxase,IPR011576:Pyridox_Oxase_put,IPR012349:Split_barrel_FMN-bd,IPR019576:Pyridoxamine_oxidase_dimer_C,IPR019740:Pyridox_Oxase_CS,	hsa00750:Vitamin B6 metabolism,hsa01100:Metabolic pathways,hsa01240:Biosynthesis of cofactors,	610090~Pyridoxamine 5'-phosphate oxidase deficiency,	PIRSF000190:Pyd_amn-ph_oxd,		KW-0664~Pyridoxine biosynthesis,		KW-0225~Disease variant,KW-0887~Epilepsy,		KW-0285~Flavoprotein,KW-0288~FMN,KW-0663~Pyridoxal phosphate,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	DOMAIN:Pyridoxamine 5'-phosphate oxidase putative,DOMAIN:Pyridoxine 5'-phosphate oxidase dimerisation C-terminal,MUTAGEN:Missing: Has no effect on the catalytic activity.,MUTAGEN:Missing: Loss of catalytic activity.,REGION:Disordered,
ENSG00000129824	ribosomal protein S4 Y-linked 1(RPS4Y1)	Homo sapiens	GO:0006412~translation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005844~polysome,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000876:Ribosomal_eS4,IPR002942:S4_RNA-bd,IPR005824:KOW,IPR013843:Ribosomal_eS4_N,IPR013845:Ribosomal_eS4_central_region,IPR014722:Rib_uL2_dom2,IPR018199:Ribosomal_eS4_N_CS,IPR032277:Ribosomal_eS4_C,IPR036986:S4_RNA-bd_sf,IPR038237:Ribosomal_eS4_central_sf,IPR041982:Ribosomal_eS4_KOW,	hsa03010:Ribosome,hsa05171:Coronavirus disease - COVID-19,		PIRSF002116:Ribosomal_S4,	SM00363:S4,						KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,		DOMAIN:RNA-binding S4,DOMAIN:S4 RNA-binding,